Posts By Alex
-
451Wire StoriesAM Best Affirms Credit Ratings of Dhipaya Insurance Public Company Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of �a-� (Excellent) of...
-
677Wire StoriesHytera at CCW 2022 Is Showcasing Convergence-Native Solutions for Critical Communications Sector
VIENNA–(BUSINESS WIRE)–#5G–Critical Communications Week (CCW) took place in Vienna, Austria on 21st June, 2022. The event has been running for over twenty...
-
1.3KWire StoriesKyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA� ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)
CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of tumours TOKYO–(BUSINESS...
-
526Wire StoriesDr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Acquisition–Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries...
-
428Wire StoriesLocix�s Warehouse Intelligence Solution Deployment Named a Recipient of Supply & Demand Chain Executive�s Top Supply Chain Projects Awards
This award spotlights successful and innovative transformation projects that deliver bottom-line value to small, medium, and large enterprises across a range of...
-
466Wire StoriesPropanc Biopharma Announces No Immediate Plans for Reverse Stock Split
Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (�Propanc� or...
-
515Wire StoriesEntegris and CMC Materials Receive China Antitrust Clearance for Pending Acquisition
Transaction Expected to Close on July 6, 2022 BILLERICA, Mass. & AURORA, Ill.–(BUSINESS WIRE)–Entegris, Inc. (NASDAQ: ENTG) and CMC Materials, Inc. (NASDAQ:...
-
489Wire StoriesGrowing Number of CAGR of 4.3% from 2022 to 2030, mTOR Inhibitors Market Size to USD 9,445 Mn by 2030 Report By Acumen Research and Consulting
Acumen Research and Consulting recently published report titled �mTOR Inhibitors Market Size, Share, Analysis Report and Region Forecast, 2022 – 2030� LOS...
-
533Wire StoriesBiolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston�s AKS-452 announced. Interim analysis shows a 91% seroconversion rate....
-
435Wire StoriesBiolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston�s AKS-452 announced. Interim analysis shows a 91% seroconversion rate....
